News

“a-Galactosidase A Loaded Nanoliposomes with Enhanced Enzymatic Activity and Intracellular Penetration”

Unit 1 of NANBIOSIS, Protein Production Platform (PPP), Unit 3, Synthesis of Peptides, Unit 20, In Vivo Experimental Platform and Unit 6, Biomaterial Processing and Nanostructuring Unit, have jointly developed the research conducted in relation with a CO2-based methodology for the one-step production of protein-nanoliposome conjugates as bio-active nanomaterials with therapeutic interest. The results have been published in Advanced Healthcare Materials: http://www.ncbi.nlm.nih.gov/pubmed/26890358

“a-Galactosidase A Loaded Nanoliposomes with Enhanced Enzymatic Activity and Intracellular Penetration I. Cabrera, I. Abasolo, J. L. Corchero, E. Elizondo, P. Rivera, E. Moreno, J. Faraudo, S. Sala, D. Bueno, E. González-Mira, M. Rivas, M. Melgarejo, D. Pulido, F. Albericio, M. Royo, A. Villaverde, M. F. García-Parajo, S. Schwartz Jr., N. Ventosa,*, and J. Veciana,*

Lysosomal storage disorders (LSD) are caused by lysosomal dysfunction usually as a consequence of deficiency of a single enzyme required for the metabolism of macromolecules such as lipids, glycoproteins and mucopolysaccharides. For instance, the lack of alpha-Galactosidase A (GLA) activity in Fabry disease patients causes the accumulation of glycosphingolipids in the vasculature leading to multiple organ pathology.

Enzyme replacement therapy (ERT), which is the most common treatment of LSD, exhibits several drawbacks mainly related to the instability and low efficacy of the exogenously administered therapeutic enzyme. In this work, the unprecedented increased enzymatic activity and intracellular penetration achieved by the association of a human recombinant GLA to nanoliposomes functionalized with RGD peptides is reported. Moreover, these new GLA loaded nanoliposomes lead to a higher efficacy in the reduction of the GLA substrate named globotriasylceramide (Gb3) in a cellular model of Fabry disease, than that achieved by the same concentration of the free enzyme. The preparation of these new liposomal formulations by DELOS-SUSP, based on the Depressurization of a CO2-Expanded Liquid Organic Solution, shows the great potential of this CO2-based methodology for the one-step production of protein-nanoliposome conjugates as bioactive nanomaterials with therapeutic interest.

“a-Galactosidase A Loaded Nanoliposomes with Enhanced Enzymatic Activity and Intracellular Penetration”

• Read More

NANBIOSIS participated in the CTLS 2016 Conference.

Jesús Izco, Coordinator of NANBIOSIS participated in Core Technologies for Life Science 2016 that took place last 12 – 15 Jun at EMBL in Heidelberg, Germany, taking a unique opportunity to listen and discuss with colleagues and peers about challenges and solutions on all aspects of core facilities and infrastructures. Special mention requires the meeting with Patrick England coordinator of ARBRE, to treat NANBIOSIS participation in the V work package of Cost Action MOBIEU.

CTLS 2016 brought together not only scientists, technicians and managers, but also decision makers and opinion leaders involved in Core Technology facilities and resource laboratories in all fields of Life Science.

At the conference the following topics were discussed:
• New technologies and methodologies developed by and with Life Science core facilities
• Project & data management and quality control in and by Life Science core facilities
• Core facility administrative, human resource and financial management
• Teaching and training by and for Life Science core facilities
• Building networks, communities and lobbies involving Life Science core facilities.

NANBIOSIS participated in the CTLS 2016 Conference.

• Read More

Research Excellence Award by the Spanish Royal Society of Chemistry to Ramón Martínez, Scientific Director of Unit 26 of NANBIOSIS

The Governing Board of the Spanish Royal Society of Chemistry (SRSQ) has agreed to grant its Research Excellence Award 2016 to Dr. Ramón Martínez Máñez, Scientific Director of Unit 26 of NANBIOSIS and Scientific Director of CIBER-BBN, in recognition of the quality and innovation of its research in the design of chrome-fluorogenic detection probes and the development of new delivery systems and their impact on biomedical applications.

Martinez Máñez is co-authored of more than 330 scientific publications in international journals. His scientific work has been cited on over 13,000 occasions. It is among the 15 most cited authors in the area of Chemistry in Spain in recent years and currently has an index h of 56. He is currently Director of the Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM) at the Politecnic University of Valencia. He has been coordinator of Project Evaluation Technology Area at the Generalitat Valenciana and member of the Committee of Experts for the Selection of Projects of the National Plan in 2010 and 2014 in the Thematic Area of Materials. Currently, he is also coordinator of the PhD Program in Chemistry and a member of the Steering Committee of the Doctoral School of the UPV, Co-chairman of the magazine ChemistryOpen published by Wiley and member of the International Advisory Board of the Chemistry journal Asian. Chem. J. and ChemPlusChem, published by Wiley

Nanbiosis U26-Research Excellence Award by the Spanish Royal Society of Chemistry to Ramón Martínez, Scientific Director of Unit 26 of NANBIOSIS

• Read More

Nanbiosis in the 2ª General Assambly of DRIVE project, Venice (16th-17th 2016)

Jesus Izco, Coordinator of NANBIOSIS and José Luis Pedraz, Scientific Director of Unit 10-Drug Formulation of NANBIOSIS and NanoBioCel Group of CIBER-BBN, participated in the 2ª General Assambly of DRIVE project, held in Venice, May 16th-17th 2016.

The second General Assembly of European project DRIVE “DIABETES-REVERSING-IMPLANTS FOR ENHANCED VIABILITY AND LONG TERM EFFICACY”, took place last 16 and 17 of May in San Servolo Island, Venice. Jesus Ciriza, from NanoBioCel group, presented the work scheduled for this first year and the results obtained.

The DRIVE, a 4-year project to be carried out by 14 European partners, among which is CIBER-BBN, develops biomaterials and new surgical devices to improve transplantation and survival of insulin-producing pancreatic islet for the treatment of diabetes.

CIBER-BBN participates in the project thought Unit 10 of NANBIOSIS with the role of:

-Development of hydrogel formulations for β-Gel

-Developing unlimited future sources of insulin-producing β-cells

-Testing β-cell function in β-Gel using 3D in vitro tissue model.

Jesus Izco, Coordinator of NANBIOSIS and José Luis Pedraz, Scientific Director of Unit 10-Drug Formulation of NANBIOSIS and NanoBioCel Group of CIBER-BBN, participated in the 2ª General Assambly of DRIVE project, held in Venice, May 16th-17th 2016.

• Read More

Last Friday, 27th May, the "Instituto de Investigación en Ingeniería de Aragón" held the "V Jornada de Jóvenes Investigadores" where phD students presented their works related to different areas: Industrial Technologies, Biomedical Engineering, Processes and Recycling and Information and Communications Technology.

Last Friday, 27th May, the “Instituto de Investigación en Ingeniería de Aragón” held the “V Jornada de Jóvenes Investigadores” where phD students presented their works related to different areas: Industrial Technologies, Biomedical Engineering, Processes and Recycling and Information and Communications Technology.

David Adolfo Sampedro Puente, member of the BSICoS, group coordinator of Unit 27 of NANBIOSIS, presented the work entitled “Unscented Kalman Filter for Unobservable Parameter Estimation in Heart Cell Signals”, supervised by Jesús Fernández Bes and Esther Pueyo Paules. This work shows a methodology to estimate unobservable parameters, such as the number of the different ion channel typologies located in the cardiomyocyte membrane, from action potential (AP) signals. This methodology was validated using synthetic AP signals simulated by stochastic computational cell models. In future, this methodology will be used to real signals, recorded in human cardiomyocytes, to help to the study of the AP temporal variability characterization.

Nanbiosis U27-Unscented Kalman Filter for Unobservable Parameter Estimation in Heart Cell Signals by David Sampedro

• Read More

A new surface for bone implants that promotes regeneration and reduces the risk of infections in which.

The Phytech project (funded by the Spanish Government through the Call INNPACTO) has recently finished with the participation of CIBER-BBN, through Unit 16 of NANBIOSIS, the University of the Balearic Islands and the companies NuMat Biomedical and Sanifit).

Unit 16 of NANBIOSIS – Surface Characterization and Calorimetry, coordinated by Dr. M. Luisa Gonzalez, has conducted tests of surface composition by surface characterization techniques (XPS and ToF-SIMS) as well as the analysis microbial response of the raised surfaces in this development

The results of this project have been published in the journal Applied Materials & Interfaces of the American Chemical Society.

For further information clic here

• Read More

Cationic nioplexes in supramolecular hydrogels as hybrid materials to deliver nucleic acids

Jose Luis Pedraz, Scientific Director of Unit 10 of NANBIOSIS Drug Formulation unit and Ramon Eritja Scientific Director of Unit U29 of NANBIOSIS Oligonucleotide Synthesis Platform (OSP) (CIBER-BBN) have participated in the entrapment of cationic nioplexes in supramolecular hydrogels and the use of these materials for transfecting cells.

This work is focused on entrapping cationic nioplexes within supramolecular hydrogels based on N-protected phenylalanine. To modulate the supramolecular hydrogel diffusion properties, hydrogels were easily tuned with ĸ-carrageenan (≤ 1%). These materials were fully characterized using rheology. The niosomal liberation in solution through hydrogels was monitored by fluorescence and this release was controlled by diffusion mechanisms. The lack of toxicity of these materials allowed these materials to be used in cell culture. Preliminary transfection results confirmed the suitability of entrapping niosomal formulations in supramolecular hydrogels and the potential opening up of alternative strategies in therapy.

This study was published in RSC Advances:

S. Grijalvo, G. Puras, J. Zárate, R. Pons, J.L. Pedraz, R. Eritja, D. Díaz. “Nioplexes encapsulated in supramolecular hybrid biohydrogels as versatile delivery platforms for nucleic acids” 2016, 6, 39688-39699. DOI: 10.1039/C6RA01005A

Nanbiosis_U10_Cationic nioplexes in supramolecular hydrogels as hybrid materials to deliver nucleic acids

• Read More

Nanobiotechnology for Diagnostics Group awarded with TECNIO grant to encourage Technology Transfer

The Nanobiotechnology for Diagnostics Group (Nb4D), the host group for the Custom Antibody Service of Unit 2 of NANBIOSIS was recently awarded with grant that ACCIÓ provides to groups who are seeking to be accredited with the TECNIO seal. The aim is to help define and boost their action plans for technology transfer.

These grants are destined at financing for 3 years the integration of these groups in the UAB-CEI sphere of the TECNIO network. The group will use this finance for activities related to the execution during the first year of a growth plan to increase their technology transfer to the private sector.

The TECNIO seal is granted by the Government of Catalonia, through ACCIÓ (Agency for Business Competitiveness) to identify the developers and facilitators of differential technologies in Catalonia.

Nanbiosis_U2_Nanobiotechnology for Diagnostics Group awarded with TECNIO grant to encourage Technology Transfer

• Read More

Unit 1 of NANBIOSIS certified with ISO 9001: 2008

Unit 1 of NANBIOSIS, Production Platform Protein (PPP) at the Autonomous University of Barcelona, directed by Dra. Neus Ferrer and coordinated by Professor Antonio Villaverde, provides the service of production and purification of recombinant proteins in different systems expression, microbial and non-microbial. This service was audited last November, based on the UNE EN ISO 9001: 2008 AENOR, who has issued a favourable certification report.

The requirements of this standard cover all aspects of management. This certification will expand and consolidate the service that the Unit 1 of NANBIOSIS is giving to companies and public sector researchers and facilitate their integration in cooperative international projects.

AENOR is a Spanish company, renowned in national and international levels, in the development of standardization and certification activities. It was, in 1996 the first Spanish entity accredited by the National Accreditation Body (ENAC)

Nanbiosis_Unit 1 of NANBIOSIS certified with ISO 9001- 2008

• Read More

Graphene Flagship for Biomedical Tecnologies – Kick off meeting April 11-14 Barcelona

On April, 11-12 took place in Barcelona the kick off meeting of the new Graphene Flagship Work Package devoted to Biomedical Technologies, one emerging application area for graphene and other 2D materials. The Kick-off event, was co-organised by Dr. Rosa Villa (CNM-IMB-CSIC, CIBER-BBN) Scientific Coordinator of Unit 8 of NANBIOSIS (in the center of the first row in the photo). More than 35 Scientifics from 14 research groups attended to the meeting

The Graphene Flagship, the EU’s biggest ever research initiative, involves the coordination research of over 150 partners from more than 20 European countries withing a timeframe of 10 years. This project is implemented as a total of 15 research Work Packages on specific science and technology topics. The new Work Package will focus on the development of implants based on graphene and 2D-materials with therapeutic functionalities for specific clinical outcomes in neurology, ophthalmology and surgery, between other disciplines that will be further developed in the next phases of the Graphene Flagship.

The launch meeting held on 11 and 12 April in the Convalescence House of the Autonomous University of Barcelona (UAB), was co-organized by the ICN2, the National Microelectronics Centre (CNM-IMB-CSIC, CIBER-BBN; researcher Dr. CSIC. Villa Rosa) and IDIBAPS. This meeting began with two lectures given by well known neuroscientists, Dr. Gerardo Conesa, chief of neurosurgery at the Hospital del Mar (Barcelona) and Dr. Xavier Navarro, the Institute of Neurosciences at the UAB and belonging to CIBERNED.

Nanbiosis_U8_Graphene Flagship for Biomedical Tecnologies

• Read More

You are here : Home / News (Page 79)